Home > Riviste > Minerva Urology and Nephrology > Fascicoli precedenti > Articles online first > Minerva Urologica e Nefrologica 2020 Dec 01

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Urologica e Nefrologica 2020 Dec 01

DOI: 10.23736/S0393-2249.20.04038-2

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Predictive factors for opioid-free management after robotic radical prostatectomy: the value of the SP® Robotic Platform

Guilherme SAWCZYN 1, Louis LENFANT 1, 2, Alireza AMINSHARIFI 1, 3, Soodong KIM 1, Jihad KAOUK 1

1 Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; 2 Sorbonne University, GRC n°5, Predictive Onco‑urology, AP‑HP, Hôpital Pitié‑Salpêtrière, Urology Department, Paris, France; 3 Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran


PDF


BACKGROUND: The objective was to evaluate perioperative factors associated with opioid-free management after robotic radical prostatectomy in a single institution.
METHODS: From January 2019 to January 2020, data from patients who underwent robotic radical prostatectomy was retrospectively entered in a pre-approved IRB database. Data were analyzed according to the postoperative opioid administration in hospital and/or after discharge. Robotic radical prostatectomy was performed using either the standard multi-port Da Vinci Si robotic platform with a transperitoneal approach(MP-RALP) or the novel DaVinci SP® robotic platform with an extraperitoneal approach(SP-EPP). Patients undergoing minimally invasive surgery were included in the "enhanced recovery after surgery"(ERAS) protocol regardless of the surgery approach.
RESULTS: During the study period, 210 patients matched the selection criteria. Of those, 158(75%) patients received opioids during the hospital stay or after discharge and 52(25%) patients never received opioids. SP-EPP surgical approach and shorter LOS were predictors of never receiving opioids (Odds Ratio [OR]=4.97, (95% CI 1.81-14.77, p=0.002 and OR=0.56, CI 95% 0.35-0.86, p=0.011, respectively). SP-EPP surgical approach was increasing the odds of remaining opioid free whether in-hospital or after discharge (OR= 11.97, 95% CI 4.8 - 32, p<0.0001 and OR=11.6, 95% CI 4.6-31, p<0.0001, respectively). Finally, a high BMI increased the odds of receiving opioid in hospital or after discharge (OR=0.89, 95% CI 0.82-0.96, p=0.003 and OR=0.89, 95% CI 0.82-0.96, p=0.002, respectively).
CONCLUSIONS: In this series, after robotic radical prostatectomy the use of a less invasive approach (SP-EPP), a shorter LOS and a lower BMI, were predictive of opioid-free status.


KEY WORDS: Opioids; Narcotics; Single port surgery; Robotic surgery; Robotic; Prostatectomy

inizio pagina